Concepedia
Statistics
Publications
60
Citations
3.3K
H-Index
27
Active since
1992
Affiliations
NewLink Genetics (United States)(Current)
Human Gene Therapy Research Institute
National Cancer Institute
Augusta University
Huntsman Cancer Institute
Charles J. Link is an author at NewLink Genetics (United States) specializing in oncology, medicine, and cancer immunotherapy.
Publications per year
1992–2021
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
Jason A. Regules, John H. Beigel, Kristopher Paolino et al. · New England Journal of Medicine · 2015 · 395 citations · Full text
Life Sciences, Infectious Diseases, Preventive Medicine +11
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
Richard Metz, Sonja Rust, James B. DuHadaway et al. · OncoImmunology · 2012 · 377 citations · Full text
Life Sciences, Immunology, Oncology +17
Radioisotope concentrator gene therapy using the sodium/iodide symporter gene.
Robert B. Mandell, Leisa Z. Mandell, Charles J. Link · PubMed · 1999 · 253 citations
Medicine, Nuclear Medicine, Oncology +17
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines.
Charles J. Link, Paul O’Connor, E Reed et al. · Molecular and Cellular Biology · 1992 · 195 citations · Full text
Medicine, Molecular Biology, Oncology +13
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
Asha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek et al. · Journal for ImmunoTherapy of Cancer · 2018 · 152 citations · Full text
Medicine, Oncology, Pharmacology +9
1–5 of 60